Shares of GeoVax Labs, Inc. (NASDAQ:GOVXW – Get Free Report) fell 7.2% during mid-day trading on Friday . The company traded as low as $0.10 and last traded at $0.10. 11,526 shares changed hands during trading, a decline of 50% from the average session volume of 23,197 shares. The stock had previously closed at $0.11.
GeoVax Labs Stock Performance
The company has a 50 day moving average price of $0.15 and a 200 day moving average price of $0.14.
About GeoVax Labs
GeoVax Labs, Inc, a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers.
Further Reading
- Five stocks we like better than GeoVax Labs
- There Are Different Types of Stock To Invest In
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- 3 Stocks to Consider Buying in October
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- What to Know About Investing in Penny Stocks
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for GeoVax Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GeoVax Labs and related companies with MarketBeat.com's FREE daily email newsletter.
